PRPO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. With no Intellectia buy signals, weakening momentum (bearish/expanding negative MACD), and no near-term catalysts, PRPO does not offer an attractive entry for an impatient buyer at the current ~$23.83 level. Best action is to hold/avoid initiating a new position now.
Trend/Momentum: Price is in a broadly bullish structure via moving averages (SMA_5 > SMA_20 > SMA_200), which typically supports an uptrend. However, momentum is currently deteriorating: MACD histogram is negative (-0.0248) and expanding lower, implying downside momentum building. RSI_6 at ~45.6 is neutral, not signaling an oversold bounce. Key levels: Pivot 24.578 is overhead (current price 23.83 is below pivot, slightly bearish near-term). Support levels at S1 22.798 then S2 21.698. Resistance at R1 26.358 and R2 27.458. Pattern-based forecast (similar candlesticks): modest upside next day (+0.89%) but slightly negative bias over the next week (-0.14%) and month (-1.28%), which does not favor an immediate buy.
Intellectia Proprietary Trading Signals
with +29.91% YoY sales.
suggests the broader trend has been constructive.
Latest quarter: 2025/Q3. Revenue increased to 6,767,000 (+29.91% YoY), and gross margin improved to 44.41 (+1.60% YoY), showing top-line growth and slightly better unit economics. However, profitability deteriorated: net income fell to -79,000 (-87.38% YoY) and EPS to -0.05 (-88.10% YoY). Net result: growth is improving, but earnings power is not yet stabilizing—weak support for an immediate buy.
No analyst rating or price target change data was provided, so there is no clear read on recent Wall Street upgrades/downgrades or target revisions. Pros view cannot be confirmed from the dataset; based on available fundamentals/technicals, the main 'pro' would be revenue growth, while the main 'con' is worsening EPS/profitability and fading momentum.
